Losing weight after Wegovy: what the evidence says and what to do

Step 1: understand what Wegovy does, and stops doing when you stop it

Semaglutide reduces appetite by mimicking GLP-1, a gut hormone that signals fullness and slows gastric emptying. While you're taking it, your body's hunger signals are substantially quieter. When you stop, the medicine clears your system within a few weeks, and those signals gradually return to their pre-treatment baseline. For most people, this means hunger comes back. Not immediately, not dramatically, but steadily.

The STEP 1 extension study, published in the New England Journal of Medicine, followed participants for a year after they stopped semaglutide 2.4mg. On average, they regained about two-thirds of the weight they had lost during the trial. That's a significant number, and it's worth sitting with. It doesn't mean the treatment failed, it means that, for many people, ongoing use is part of what makes it effective. Weight management of this kind is increasingly understood as a long-term condition, not a short course with a fixed endpoint.

The practical implication: if you're planning to stop Wegovy, plan deliberately. Don't wait until the regain is well underway before thinking about what comes next. One quick habit that takes under a minute is weighing yourself once a week on the same day, at the same time, noting the number. Trends over four to six weeks tell you far more than daily fluctuations.

Step 2: distinguish between stopping by choice and stopping because progress has stalled

These are two quite different situations, and they need different responses.

If you're considering stopping because you've reached a weight you're happy to maintain and you feel ready to manage without medication, that's a planned, positive decision, and it's worth reading about whether coming off Wegovy after losing weight is right for you before making that call. The guidance from NHS England on weight-management injections recommends wrapping treatment in dietary support and activity changes precisely to help people maintain habits after they stop. The more those habits are genuinely embedded before you stop, the slower and smaller any rebound tends to be.

If you've stopped because of side effects, cost, supply or another practical reason, the picture is different again. You can find a breakdown of what Wegovy costs privately if cost was the factor. And if the weight is now returning faster than you expected, that's useful clinical information, not a reason for alarm. A prescriber who can see your current weight, your history and your goals is the right person to advise on whether restarting, switching or adjusting your approach makes most sense.

A third scenario: some people find weight loss slows or stops while they're still taking Wegovy. That's a separate topic, what it means when weight loss plateaus on Wegovy covers why this happens and what options exist.

Step 3: think about what comes after Wegovy, practically and clinically

There's nothing wrong with wanting to stop. The question is whether the conditions that made weight loss hard in the first place have genuinely shifted, or whether they'll reassert themselves once the pharmacological support is gone. For some people, one or two years of treatment is enough to reset habits and reach a stable point. For others, longer-term use makes more sense clinically. If you want a clearer picture of what to expect while you're still on the medication, our guide to losing weight on Wegovy walks through how the process typically unfolds.

NICE's appraisal of semaglutide for weight management (TA875) notes that treatment should be reviewed if less than five percent of weight has been lost after six months on the maintenance dose, which implies that at some point an active assessment of whether the benefit still justifies continuing is part of good care. That review cuts both ways: it's also when a prescriber might confirm that continuing is absolutely the right call.

If you stopped Wegovy some time ago and weight has since returned, restarting is clinically possible for many people. Semaglutide is licensed for ongoing use in eligible adults, and the titration process simply begins again from the starting dose. You can read more about how semaglutide works as a treatment and whether it might fit your situation now. There's also the option of tirzepatide (Mounjaro), which works across two receptor pathways rather than one and has shown greater average weight loss in head-to-head trials, something worth discussing if a previous course of Wegovy didn't produce the results you hoped for. Understanding what happens to your weight after stopping Wegovy can help you decide whether restarting or switching is the more sensible route.

For a broader look at where Wegovy sits within the available options, the weight-loss treatments overview covers how the licensed medicines compare. Our clinical team, detailed on the clinical team page, reviews every consultation personally. If you'd like to talk through where you are and what makes sense next, speaking to our prescribers is a straightforward starting point.